Exact Mass: 233.08

Exact Mass Matches: 233.08

Found 19 metabolites which its exact mass value is equals to given mass value 233.08, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

4-(3-Pyridin-2-yl-[1,2,4]oxadiazol-5-yl)-butyric acid

4-[3-(pyridin-2-yl)-1,2,4-oxadiazol-5-yl]butanoic acid

C11H11N3O3 (233.08)


   

polyandrocarpamine A

polyandrocarpamine A

C11H11N3O3 (233.08)


   

5-Acetoacetamino benzimidazolone

3-Oxo-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)butanamide

C11H11N3O3 (233.08)


CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2379; ORIGINAL_PRECURSOR_SCAN_NO 2376 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2374; ORIGINAL_PRECURSOR_SCAN_NO 2372 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2378; ORIGINAL_PRECURSOR_SCAN_NO 2375 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2368; ORIGINAL_PRECURSOR_SCAN_NO 2365 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2441; ORIGINAL_PRECURSOR_SCAN_NO 2438 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2381; ORIGINAL_PRECURSOR_SCAN_NO 2378

   

N-BENZYLOXYMETHYL-4-NITRO-IMIDAZOLE

N-BENZYLOXYMETHYL-4-NITRO-IMIDAZOLE

C11H11N3O3 (233.08)


   

1H-1,2,4-Triazole-1-aceticacid,4,5-dihydro-4-(4-methylphenyl)-5-oxo-

1H-1,2,4-Triazole-1-aceticacid,4,5-dihydro-4-(4-methylphenyl)-5-oxo-

C11H11N3O3 (233.08)


   

Ethyl2,5-dihydro-5-oxo-1-phenyl-1H-1,2,4-triazole-3-carboxylate

Ethyl2,5-dihydro-5-oxo-1-phenyl-1H-1,2,4-triazole-3-carboxylate

C11H11N3O3 (233.08)


   

3-(3-Nitrophenyl)-5-propyl-1,2,4-oxadiazole

3-(3-Nitrophenyl)-5-propyl-1,2,4-oxadiazole

C11H11N3O3 (233.08)


   

1-(4-METHOXYBENZYL)-4-NITRO-1H-IMIDAZOLE

1-(4-METHOXYBENZYL)-4-NITRO-1H-IMIDAZOLE

C11H11N3O3 (233.08)


   

1-(2-METHOXY-4-NITROPHENYL)-4-METHYL-1H-IMIDAZOLE

1-(2-METHOXY-4-NITROPHENYL)-4-METHYL-1H-IMIDAZOLE

C11H11N3O3 (233.08)


   

4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)butanoic acid

4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)butanoic acid

C11H11N3O3 (233.08)


   

1-(4-Methoxy-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid

1-(4-Methoxy-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid

C11H11N3O3 (233.08)


   

methyl (E)-3-(furan-2-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

methyl (E)-3-(furan-2-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C11H11N3O3 (233.08)


   

Methyl 2-(5-hydroxy-1-(pyridin-2-yl)-1H-pyrazol-3-yl)acetate

Methyl 2-(5-hydroxy-1-(pyridin-2-yl)-1H-pyrazol-3-yl)acetate

C11H11N3O3 (233.08)


   

5-Amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylic acid

5-Amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylic acid

C11H11N3O3 (233.08)


   

2-(4-(ACETYLAMINO)-3-NITROPHENYL)PROPIONITRILE

2-(4-(ACETYLAMINO)-3-NITROPHENYL)PROPIONITRILE

C11H11N3O3 (233.08)


   

3-(4-Nitrophenyl)-5-propyl-1,2,4-oxadiazole

3-(4-Nitrophenyl)-5-propyl-1,2,4-oxadiazole

C11H11N3O3 (233.08)


   

2,1,3-Benzoxadiazol-5-yl(morpholin-4-yl)methanone

2,1,3-Benzoxadiazol-5-yl(morpholin-4-yl)methanone

C11H11N3O3 (233.08)


CX 717 is a positive allosteric modulator of AMPA receptor. Antidepressant-like effect. CX 717 can be used for the research of adult attention deficit hyperactivity disorder (ADHD)[1][2].

   

1-Nitroso-L-tryptophan

1-Nitroso-L-tryptophan

C11H11N3O3 (233.08)


   

Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-

Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-

C11H11N3O3 (233.08)